Projects funded by the NCN

Role of the selected anti-tumor agents transported by electropermeabilization to the drug-sensitive and drug-resistant c...

Call: PRELUDIUM 8 , Panel: NZ7

Principal investigator: dr Joanna Barbara Weżgowiec

Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

Cancer stem cells signaling pathways as a therapeutic terget in ovarian cancer chemotherapy

Call: OPUS 7 , Panel: NZ5

Principal investigator: prof. Maciej Zabel

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Evaluation of the contribution of telomerase regulation with TMPyP4 and cisplatin to multidrug resistance in breast canc...

Call: PRELUDIUM 7 , Panel: NZ7

Principal investigator: dr Natalia Konieczna

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny, Katedra i Zakład Chemii Klinicznej i Diagnostyki Molekularnej

Efficiency of photodynamic reaction enhanced electroporation in human cancer cells sensitive and resistant to chemothera...

Call: SONATA 1 , Panel: NZ4

Principal investigator: dr Julita Kulbacka

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

Parallel microevolution of metabolic plasticity and chemoresistance of cancer cells: a key to understanding cancer relap...

Call: OPUS 28 , Panel: NZ3

Principal investigator: prof. Jarosław Piotr Czyż

Uniwersytet Jagielloński

Evaluation of the relationship between doxorubicin resistance, epithelial-mesenchymal plasticity, and effects of selecte...

Call: PRELUDIUM 23 , Panel: NZ5

Principal investigator: Dominika Kunachowicz

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu

New strategy for overcoming resistance to chemotherapy of ovarian cancer by modulation of the canonical and non-canonica...

Call: OPUS 22 , Panel: NZ5

Principal investigator: dr hab. Radosław Januchowski

Uniwersytet Zielonogórski, Collegium Medicum

Reversible senescence as a new mechanism of cancer cell resistance for chemotherapy. Analysis of the mechanism of cancer...

Call: SONATINA 5 , Panel: NZ3

Principal investigator: dr Karolina Anna Staniak

Politechnika Warszawska, Wydział Chemiczny

Dual CBR1-AKR1C3 inhibitors as a new approach to improve effectiveness and safety of anthracycline therapy.

Call: PRELUDIUM 19 , Panel: NZ7

Principal investigator: Marek Andrzej Jamrozik

Uniwersytet Jagielloński, Collegium Medicum

Polymorphisms of miRNA genes and in the 3'UTR region of the ADME genes in breast cancer patients treated with FAC (5-flu...

Call: SONATA 11 , Panel: NZ5

Principal investigator: dr Jolanta Ewa Pamuła-Piłat

Narodowy lnstytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy lnstytut Badawczy

The evaluation of electroporation and electrochemotherapy activity in human cancer cells sensitive and resistant to chem...

Call: PRELUDIUM 10 , Panel: NZ7

Principal investigator: dr Nina Rembiałkowska

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Lekarski